Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis
Top Cited Papers
Open Access
- 27 January 2016
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (6), 1432-1441
- https://doi.org/10.1002/art.39594
Abstract
Objective End‐stage renal disease (ESRD) is a major consequence of lupus nephritis, but how this risk has changed over time is unknown. We conducted this systematic review to examine changes in ESRD among adults with lupus nephritis from 1971 to 2015 and to estimate risks of ESRD among contemporary patients. Methods We searched PubMed, Embase, and the Cochrane Database of Systematic Reviews for cohort studies and clinical trials on ESRD in adults with lupus nephritis. We analyzed studies from developed and developing countries separately. The outcome was probability of ESRD at 5, 10, and 15 years of lupus nephritis. Results We included 187 articles that reported on 18,309 patients. In developed countries, the 5‐year risk of ESRD decreased from 16% (95% confidence interval [95% CI] 14–17%) in 1970–1979 to 11% (95% CI 10–12%) in the mid‐1990s and then plateaued. ESRD risks at 10 years and 15 years showed steeper declines in the 1970s and 1980s but also plateaued in 1993–1997, with a notable increase in the late 2000s. The decrease in risk after 1980 coincided with increased use of cyclophosphamide. The 15‐year ESRD risk was higher in developing countries than in developed countries. Patients with class IV lupus nephritis had the greatest risk of ESRD, with a 15‐year risk of 44% during the 2000s. Conclusion Risks of ESRD in lupus nephritis improved between the 1970s and the mid‐1990s and then plateaued, with an increase in the late 2000s. This pattern suggests limitations in the effectiveness of, or access to, current treatments.Keywords
Funding Information
- Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
This publication has 40 references indexed in Scilit:
- Features and outcomes of lupus nephritis in Morocco: analysis of 114 patientsInternational Journal of Nephrology and Renovascular Disease, 2013
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnnals Of The Rheumatic Diseases, 2012
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Unmet medical needs in systemic lupus erythematosusArthritis Research & Therapy, 2012
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Depression, medication adherence, and service utilization in systemic lupus erythematosusArthritis Care & Research, 2009
- Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004The Journal of Rheumatology, 2009
- Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysThe Lancet, 2007
- Time to Renal Disease and End-Stage Renal Disease in PROFILE: A Multiethnic Lupus CohortPLoS Medicine, 2006